ProShare Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $209K | Sell |
6,312
-1,195
| -16% | -$50.6K | ﹤0.01% | 1552 |
|
|
2025
Q4 | $348K | Buy |
7,507
+356
| +5% | +$14.9K | ﹤0.01% | 1364 |
|
|
2025
Q3 | $250K | Sell |
7,151
-1,205
| -14% | -$41.9K | ﹤0.01% | 1559 |
|
|
2025
Q2 | $247K | Sell |
8,356
-622
| -7% | -$17.7K | ﹤0.01% | 1581 |
|
|
2025
Q1 | $268K | Sell |
8,978
-2,218
| -20% | -$67.8K | ﹤0.01% | 1488 |
|
|
2024
Q4 | $321K | Buy |
11,196
+2,506
| +29% | +$82.9K | ﹤0.01% | 1580 |
|
|
2024
Q3 | $336K | Buy |
8,690
+1,637
| +23% | +$58.4K | ﹤0.01% | 1389 |
|
|
2024
Q2 | $227K | Sell |
7,053
-1,773
| -20% | -$61.5K | ﹤0.01% | 1467 |
|
|
2024
Q1 | $343K | Buy |
8,826
+281
| +3% | +$9.83K | ﹤0.01% | 1342 |
|
|
2023
Q4 | $263K | Buy |
+8,545
| New | +$214K | ﹤0.01% | 1475 |
|
|
2022
Q2 | – | Sell |
-11,134
| Closed | -$227K | – | 1853 |
|
|
2022
Q1 | $227K | Sell |
11,134
-2,359
| -17% | -$44.6K | ﹤0.01% | 1804 |
|
|
2021
Q4 | $252K | Buy |
13,493
+467
| +4% | +$9.1K | ﹤0.01% | 1890 |
|
|
2021
Q3 | $257K | Sell |
13,026
-3,396
| -21% | -$73.4K | ﹤0.01% | 1657 |
|
|
2021
Q2 | $388K | Buy |
16,422
+1,414
| +9% | +$32.7K | ﹤0.01% | 1715 |
|
|
2021
Q1 | $356K | Buy |
15,008
+2,065
| +16% | +$49.1K | ﹤0.01% | 1690 |
|
|
2020
Q4 | $259K | Buy |
12,943
+3,171
| +32% | +$61.9K | ﹤0.01% | 1710 |
|
|
2020
Q3 | $203K | Sell |
9,772
-380
| -4% | -$6.86K | ﹤0.01% | 1408 |
|
|
2020
Q2 | $178K | Buy |
+10,152
| New | +$199K | ﹤0.01% | 1489 |
|
|
2020
Q1 | – | Sell |
-11,617
| Closed | -$239K | – | 1249 |
|
|
2019
Q4 | $239K | Sell |
11,617
-1,105
| -9% | -$18.4K | ﹤0.01% | 1477 |
|
|
2019
Q3 | $146K | Sell |
12,722
-134
| -1% | -$1.53K | ﹤0.01% | 1495 |
|
|
2019
Q2 | $169K | Sell |
12,856
-1,650
| -11% | -$22.1K | ﹤0.01% | 1470 |
|
|
2019
Q1 | $220K | Buy |
14,506
+142
| +1% | +$2.27K | ﹤0.01% | 1415 |
|
|
2018
Q4 | $247K | Sell |
14,364
-2,772
| -16% | -$47.4K | ﹤0.01% | 1259 |
|
|
2018
Q3 | $253K | Sell |
17,136
-617
| -3% | -$10.9K | ﹤0.01% | 1455 |
|
|
2018
Q2 | $423K | Sell |
17,753
-504
| -3% | -$12.4K | ﹤0.01% | 1201 |
|
|
2018
Q1 | $466K | Sell |
18,257
-3,006
| -14% | -$71.6K | ﹤0.01% | 1124 |
|
|
2017
Q4 | $393K | Buy |
21,263
+3,050
| +17% | +$43.7K | ﹤0.01% | 1252 |
|
|
2017
Q3 | $191K | Buy |
18,213
+1,088
| +6% | +$12K | ﹤0.01% | 1290 |
|
|
2017
Q2 | $214K | Sell |
17,125
-42
| -0.2% | -$415 | ﹤0.01% | 1315 |
|
|
2017
Q1 | $173K | Sell |
17,167
-4,379
| -20% | -$65.1K | ﹤0.01% | 1469 |
|
|
2016
Q4 | $335K | Buy |
21,546
+5,371
| +33% | +$89.3K | ﹤0.01% | 1292 |
|
|
2016
Q3 | $312K | Sell |
16,175
-2,999
| -16% | -$35.6K | ﹤0.01% | 1139 |
|
|
2016
Q2 | $227K | Buy |
19,174
+861
| +5% | +$14.2K | ﹤0.01% | 1349 |
|
|
2016
Q1 | $332K | Buy |
18,313
+708
| +4% | +$12.9K | ﹤0.01% | 1162 |
|
|
2015
Q4 | $484K | Buy |
+17,605
| New | +$371K | 0.01% | 1044 |
|
Other funds holding COLL
EAM
VCM
